Second malignancies in Hodgkin's disease.
D003609:Dactinomycin / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006689:Hodgkin Disease / Q000628:therapy*; D006801:Humans; D009381:Neoplasms, Radiation-Induced / Q000517:prevention & control*
D003609:Dactinomycin; D004317:Doxorubicin